1 / 10

Pharma Commercial Insights Can be Improved With Artificial Intelligence

The focus of all Pharma Commercial Insights is to identify the source of activity. 25 years ago, pharmaceutical companies focused their analytics on identifying the right doctor to work with, based on sales or prescriptions generated by doctors. Things are no longer simple for them. Regulations have led to structural changes in the healthcare market since the turn of the decade, making it much more difficult to sell and market pharmaceuticals, even if operating margins are subject to pressure. <br>

telliususa
Download Presentation

Pharma Commercial Insights Can be Improved With Artificial Intelligence

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Pharma Commercial Insights Can be Improved With Artificial Intelligence

  2. Analytics has been at the heart of sales force strategy for a long time. Most large pharmaceutical companies mine data to guide sales goals, sales force size, business structure and planning.  

  3. It's important to note that AI algorithms don't just invent information. They need to derive  actionable insights from the data you already have. An important first step for any organisationlooking to use Artificial Intelligence is to put their data in order. The benefits of AI-driven insights are clear, but these capabilities will not be achieved if an organisation'sdata management practices remain at a fundamental level.

  4. Pharma and Life Sciences: Improving Sales and Commercial Effectiveness

  5. As pharmaceutical industry executives grapple with an ever-increasing array of complexities, costs, and regulations, many are turning to artificial intelligence (AI) as a possible solution. In fact, a recent global pharmaceutical industry market report shows that spending on AI will exceed $3.6 billion by 2026. Use cases for this technology include applications for discovery, manufacturing, diagnostic support, drug marketing and business operations.

  6. Especially in the pharmaceutical industry, all of the requirements for data integrity, compliance and government oversight  create an environment where risk reduction often trumps continuous innovation. However, pharma companies can use best practices to ease the transition to AI tools that can provide insights and shortcuts.

  7. The focus of all Pharma Commercial Insights is to identify the source of activity. 25 years ago, pharmaceutical companies focused their analytics on identifying the right doctor to work with, based on  sales or prescriptions generated by doctors. Things are no longer simple for them.

  8. Fast Ad Hoc Queries, Insights, & AI powered by Dual Analytics

  9. For more details please visit our website. https://www.tellius.com/

More Related